|
Edetate Disodium
|
|
Disodium EDTA; Endrate
|
Edetate Disodium Clinical Trials
- Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
ClinicalTrials.gov Identifier: NCT00107419 - Active, not recruiting
Chondrosarcoma
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00060190 - Active, not recruiting
advanced malignant mesothelioma; epithelial mesothelioma; sarcomatous mesothelioma
- Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00072397 - Active, not recruiting
localized malignant mesothelioma
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00053209 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00087087 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
- Pemetrexed Disodium and Either Cisplatin or Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062088 - Active, not recruiting
extensive stage small cell lung cancer
- Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
ClinicalTrials.gov Identifier: NCT00059865 - Active, not recruiting
advanced adult primary liver cancer; unresectable gallbladder cancer; unresectable extrahepatic bile duct cancer; ...
- Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00022646 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00049426 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas
- Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
ClinicalTrials.gov Identifier: NCT00087113 - Active, not recruiting
cervical squamous cell carcinoma; recurrent cervical cancer; stage III cervical cancer; stage IVA cervical cancer; stage IVB cervical cancer
- Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00268437 - Active, not recruiting
Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma of the Esophagus; Stage III Esophageal Cancer; Stage II Esophageal Cancer
- Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00101283 - Recruiting
advanced malignant mesothelioma; recurrent malignant mesothelioma
- Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00227630 - Active, not recruiting
Malignant Mesothelioma
- New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis
ClinicalTrials.gov Identifier: NCT00269438 - Active, not recruiting
Ulcerative Colitis
- Open-Label, Long-Term Balsalziade Disodium Tablet Ulcerative Colitis Study
ClinicalTrials.gov Identifier: NCT00486031 - Active, not recruiting
Inflammatory Bowel Disease; Ulcerative Colitis
- Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00268489 - Active, not recruiting
Recurrent Non-Small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer
- Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00227565 - Recruiting
Extensive Stage Small Cell Lung Cancer
- Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
ClinicalTrials.gov Identifier: NCT00369629 - Recruiting
Lymphoma
- Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
ClinicalTrials.gov Identifier: NCT00276783 - Recruiting
Adult Astrocytic Tumors; Adult Brain Tumor; Adult Oligodendroglial Tumors; Adult Tumors Metastatic to Brain; Mixed Gliomas; ...
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00407550 - Active, not recruiting
Lung Cancer
- A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00461786 - Active, not recruiting
Ovarian Cancer; Peritoneal Cancer
- Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00390000 - Recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Pemetrexed Disodium in Treating Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00265785 - Recruiting
Bronchoalveolar Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer; Adenocarcinoma of the Lung; ...
- Pemetrexed Disodium in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
ClinicalTrials.gov Identifier: NCT00459147 - Recruiting
Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma
- Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00334594 - Recruiting
Malignant Mesothelioma
- AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00410904 - Recruiting
Lung Cancer
- LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function
ClinicalTrials.gov Identifier: NCT00003706 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00301808 - Recruiting
Lung Cancer
- Pemetrexed Disodium, Carboplatin, and Radiation Therapy with Or Without Cetuximab in Treating Patients with Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00117962 - Recruiting
stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
- Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00438204 - Recruiting
Lung Cancer
- Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00234052 - Recruiting
Lung Cancer
- Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00454194 - Recruiting
Lung Cancer
- Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
ClinicalTrials.gov Identifier: NCT00387322 - Recruiting
Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006007 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00248495 - Recruiting
Lung Cancer
- Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00227539 - Recruiting
Lung Cancer
- Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00389688 - Recruiting
Lung Cancer
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
ClinicalTrials.gov Identifier: NCT00424242 - Recruiting
Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Metastatic Cancer; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Secondary Myelofibrosis; Unspecified Adult Solid Tumor, Protocol Specific
- Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
ClinicalTrials.gov Identifier: NCT00070473 - Completed
unspecified childhood solid tumor, protocol specific
- Pemetrexed Disodium in Treating Patients With Locally Advanced or Metastatic Recurrent Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00039260 - No longer recruiting
recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
- An Effectiveness & Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy
ClinicalTrials.gov Identifier: NCT00261599 - Completed
Colonoscopy; Colon Polyps; Endoscopic Outcomes; Endoscopic Sedation; Endoscopy; Conscious Sedation
- Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
ClinicalTrials.gov Identifier: NCT00096187 - Completed
good prognosis metastatic gestational trophoblastic tumor; recurrent gestational trophoblastic tumor; nonmetastatic gestational trophoblastic tumor
- A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.
ClinicalTrials.gov Identifier: NCT00327392 - Completed
Procedural Sedation
- An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy
ClinicalTrials.gov Identifier: NCT00306722 - Completed
Bronchoscopy; Anesthesia
- Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
ClinicalTrials.gov Identifier: NCT00408174 - Completed
Inflammatory Bowel Disease; Ulcerative Colitis
- Safety and Efficacy of GPI 15715 for Sedation in the ICU Setting.
ClinicalTrials.gov Identifier: NCT00125398 - Completed
Postoperative sedation
- Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
ClinicalTrials.gov Identifier: NCT00389805 - Completed
Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
ClinicalTrials.gov Identifier: NCT00087100 - Suspended
recurrent endometrial cancer; endometrial adenocarcinoma; stage III endometrial cancer; stage IV endometrial cancer
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
